Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The time-honored Edisonian trial-and-error process of discovery is slow and labor-intensive. This hampers the development of urgently needed new technologies for ...
Asianet Newsable on MSN
Anthropic AI model generates 35,000 antibody designs for drug discovery
Anthropic’s Claude AI has successfully generated 35,000 antibody designs for potential allergy treatments, demonstrating ...
Holyvolt announced that it has completed the acquisition of U.S.-based Wildcat Discovery Technologies, a company known for its work in battery materials discovery. The deal brings together Holyvolt’s ...
In a 2026 industry outlook interview, Laine Mello, Ecolab Life Sciences, details how AI and Pharma 4.0 speed up discovery and production while navigating industry hurdles Laine Mello, director of ...
Dublin, Oct. 15, 2026 (GLOBE NEWSWIRE)-- "mRNA Drug Discovery and Manufacturing Platforms Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
Biopharmaceutical manufacturing has been stretched thin for the past two years, limited both by capacity and a lack of standardization that makes it challenging to transfer technology and scale ...
Researchers have created a novel 3D printing method that produces materials in ways that conventional manufacturing can't match. The time-honored Edisonian trial-and ...
The time-honored Edisonian trial-and-error process of discovery is slow and labor-intensive. This hampers the development of urgently needed new technologies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results